Intas Pharmaceuticals Limited Irbesartan Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Irbesartan Export Records India — #9 Exporter, 156 Shipments, $1.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Irbesartan

India Pharmaceutical Trade Intelligence

$106.3M123 Suppliers68 CountriesHS 30049079

ExportsIndia → UNITED STATES37.2%India → FRANCE15.4%

ImportsSPAIN → India$149.9K UNITED STATES → India$19.2K

#1 Buyer: MACLEODS PHARMA

Intas Pharmaceuticals Limited — Irbesartan Exporter #9 | $1.8M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Irbesartan Exporter Profile

Indian Pharmaceutical Exporter · #9 for Irbesartan · $1.8M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #9 Indian exporter of Irbesartan with $1.8M in export value and 156 verified shipments. Intas Pharmaceuticals Limited holds a 1.7% market share in Irbesartan exports across 5 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Irbesartan Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Irbesartan export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Irbesartan?

Country	Value	Shipments	Share
PHILIPPINES	$1.2M	38	80.6%
UNITED KINGDOM	$149.0K	27	10.3%
NETHERLANDS	$116.7K	46	8.1%
ITALY	$14.4K	3	1.0%
MALTA	$457	42

Who Are the Top Buyers of Irbesartan from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
ONE DEXCEL PHARMA INC.	PHILIPPINES	$817.1K	28
TO THE ORDER	PHILIPPINES	$233.0K	8
ACCORD UK	UNITED KINGDOM	$148.9K	19
ONE DEXCEL PHARMA INC	PHILIPPINES	$112.3K	3
BROCACEF NL : HUB	NETHERLANDS	$55.9K	19
ALLOGA FRANCE	NETHERLANDS	$52.0K	23
ACCORD HEALTHCARE ITALIA SRL.	ITALY	$9.6K	1
BROCACEF NL:HUB	NETHERLANDS	$8.8K	4
ACCORD HEALTHCARE ITALIA SRL	ITALY	$4.8K	2
PHARMADOX HEALTHCARE LTD	MALTA	$443	40

Intas Pharmaceuticals Limited supplies Irbesartan to 12 buyers globally. The largest buyer is ONE DEXCEL PHARMA INC. (PHILIPPINES), followed by TO THE ORDER (PHILIPPINES) and ACCORD UK (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Irbesartan Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARMA DRUG&MED:VIRBEZ 300(IRBESARTAN 30	$183.8K	6
PHARM DRUG&MED:VIRBEZ 300(IRBESARTAN 300MG TAB EACH FILM COATED TABLET CONT:IRBESARTAN PH.EUR 300MG COL:TITANI(ASPERINV)NOS	$156.6K	6
PHARM DRUG&MED VIRBEZ 300 (IRBESARTAN 300MG TABLETS EACH FILM COATED TABLET CONT:IRBESARTAN PH.EUR 300MG COLOU(ASPERINV)	$144.6K	3
PHARMA DRUG&MED:BELIZAR 300 IRBESARTAN2X	$123.6K	4
PHARM DRUG&MED:VIRBEZ 300 (IRBESARTAN 300MG TABLETS EACH FILM COATED TABLET CONT:IRBESARTAN PH.EUR. 300 MG(ASPERINV)	$100.0K	2
PHARMA DRUGS & MEDI Irbesartan 150 mg Fi	$73.6K	3
PHARMA DRUGS & MEDI IRBESARTAN 150 MG FILM-COATED TABLETS AS PER INVOICENOS	$54.6K	6
PHARM DRUG&MED:VIRBEZ 300(IRBESARTAN 300MG TABLETS EACH FILM COATED TABLET CONT:IRBESARTAN PH.EUR 300MG COLOUR(ASPERINV)	$52.4K	2
PHARMACEUTICAL DRUGS AND MEDICINE VIRBEZ 300 IRBESARTAN 300MG TABLETS AS PERINVOICE	$50.0K	1
PHARM DRUG&MED:VIRBEZ 300 IRBESARTAN 300MG TABLETS ECH FLM CTD TAB CONT-IRBESARTAN PH.EUR. 300 MG.. ASPERINV	$50.0K	1

Intas Pharmaceuticals Limited exports 64 distinct Irbesartan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUG&MED:VIRBEZ 300(IRBESARTAN 30 with 6 shipments worth $183.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Irbesartan Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
7	AUROBINDO PHARMA LTD	$2.7M	251	4	$10.7K
8	ZYDUS LIFESCIENCES LIMITED	$2.4M	162	6	$15.1K
9	INTAS PHARMACEUTICALS LIMITED ★	$1.8M	156	5	$11.5K
11	JUBILANT GENERICS LIMITED	$1.3M	84	7	$15.1K
12	MICRO LABS LIMITED	$1.3M	41	6	$30.8K

Intas Pharmaceuticals Limited ranks #9 among 123 Indian Irbesartan exporters. Average shipment value of $11.5K compared to the market average of $473.0K. The closest competitors by value are AUROBINDO PHARMA LTD and ZYDUS LIFESCIENCES LIMITED.

Which Indian Ports Ship Irbesartan Exports?

Port	Shipments	% Share
NHAVA SHEVA SEA (INNSA1)	284	10.6%
SAHAR AIR	197	7.4%
SAHAR AIR CARGO ACC (INBOM4)	170	6.4%
JNPT/ NHAVA SHEVA SEA	147	5.5%
DELHI AIR	135	5.1%
DELHI AIR CARGO ACC (INDEL4)	133	5.0%
JNPT	129	4.8%
MUNDRA SEA (INMUN1)	108	4.0%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Irbesartan Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Irbesartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 156 individual customs records matching Intas Pharmaceuticals Limited exporting Irbesartan, covering 64 formulations to 5 countries via 12 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 68+ countries, 366+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Irbesartan

Irbesartan

Intas Pharmaceuticals Limited — Irbesartan Exporter Profile

Intas Pharmaceuticals Limited — Irbesartan Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Irbesartan?

Who Are the Top Buyers of Irbesartan from Intas Pharmaceuticals Limited?

What Is India's Total Irbesartan Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Irbesartan Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Irbesartan Exporters?

What Irbesartan Formulations Does Intas Pharmaceuticals Limited Export?

Regulatory Requirements: Exporting Irbesartan to Key Markets

United Kingdom — MHRA

How Does Intas Pharmaceuticals Limited Compare to Nearest Irbesartan Exporters?

Which Indian Ports Ship Irbesartan Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Irbesartan Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Irbesartan Export Data from Intas Pharmaceuticals Limited

Irbesartan Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source